BRIEF-Aurinia Pharmaceuticals Q4 Product Revenue USD 74.173 Million

Reuters02-26
BRIEF-Aurinia Pharmaceuticals Q4 Product Revenue USD 74.173 Million

Feb 26 (Reuters) - Aurinia Pharmaceuticals Q4 operating expenses USD 43.875 million.

  • Q4 pretax profit USD 35.69 million
  • Q4 net income USD 210.794 million
  • Q4 operating income USD 33.239 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment